HYDRO-RIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hydro-ride, and when can generic versions of Hydro-ride launch?
Hydro-ride is a drug marketed by Par Pharm and is included in one NDA.
The generic ingredient in HYDRO-RIDE is amiloride hydrochloride; hydrochlorothiazide. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amiloride hydrochloride; hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hydro-ride
A generic version of HYDRO-RIDE was approved as amiloride hydrochloride; hydrochlorothiazide by BARR on May 10th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDRO-RIDE?
- What are the global sales for HYDRO-RIDE?
- What is Average Wholesale Price for HYDRO-RIDE?
Summary for HYDRO-RIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | HYDRO-RIDE at DailyMed |
US Patents and Regulatory Information for HYDRO-RIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Pharm | HYDRO-RIDE | amiloride hydrochloride; hydrochlorothiazide | TABLET;ORAL | 070347-001 | Dec 25, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
